BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25892718)

  • 1. Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines.
    Shin D; Park KJ; Lee H; Cho EY; Kim MS; Hwang MH; Kim SI; Ahn DH
    Virus Res; 2015 Jun; 204():40-6. PubMed ID: 25892718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing.
    Donis RO; ; Davis CT; Foust A; Hossain MJ; Johnson A; Klimov A; Loughlin R; Xu X; Tsai T; Blayer S; Trusheim H; Colegate T; Fox J; Taylor B; Hussain A; Barr I; Baas C; Louwerens J; Geuns E; Lee MS; Venhuizen O; Neumeier E; Ziegler T
    Vaccine; 2014 Nov; 32(48):6583-90. PubMed ID: 24975811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid sequence identity between the HA1 of influenza A (H3N2) viruses grown in mammalian and primary chick kidney cells.
    Katz JM; Webster RG
    J Gen Virol; 1992 May; 73 ( Pt 5)():1159-65. PubMed ID: 1588320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host cell-mediated variation in H3N2 influenza viruses.
    Katz JM; Naeve CW; Webster RG
    Virology; 1987 Feb; 156(2):386-95. PubMed ID: 3811239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic and structural characterization of multiple subpopulations of H3N2 influenza virus from an individual.
    Katz JM; Webster RG
    Virology; 1988 Aug; 165(2):446-56. PubMed ID: 3407150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody response in humans to influenza virus type B host-cell-derived variants after vaccination with standard (egg-derived) vaccine or natural infection.
    Harmon MW; Rota PA; Walls HH; Kendal AP
    J Clin Microbiol; 1988 Feb; 26(2):333-7. PubMed ID: 3343328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation.
    Genzel Y; Dietzsch C; Rapp E; Schwarzer J; Reichl U
    Appl Microbiol Biotechnol; 2010 Sep; 88(2):461-75. PubMed ID: 20617311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological studies with influenza A(H1N1) viruses cultivated in eggs or in a canine kidney cell line (MDCK).
    Oxford JS; Corcoran T; Knott R; Bates J; Bartolomei O; Major D; Newman RW; Yates P; Robertson J; Webster RG
    Bull World Health Organ; 1987; 65(2):181-7. PubMed ID: 3496984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Single-Step Method for Harvesting Influenza Viral Particles from MDCK Cell Culture Supernatant with High Yield and Effective Impurity Removal.
    Liu S; Li J; Cheng Q; Duan K; Wang Z; Yan S; Tian S; Wang H; Wu S; Lei X; Yang Y; Ma N
    Viruses; 2024 May; 16(5):. PubMed ID: 38793649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs.
    Katz JM; Webster RG
    J Infect Dis; 1989 Aug; 160(2):191-8. PubMed ID: 2760480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of antigenically distinct variants of influenza C viruses by the host cell.
    Umetsu Y; Sugawara K; Nishimura H; Hongo S; Matsuzaki M; Kitame F; Nakamura K
    Virology; 1992 Aug; 189(2):740-4. PubMed ID: 1641987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glyco-engineered MDCK cells display preferred receptors of H3N2 influenza absent in eggs used for vaccines.
    Kikuchi C; Antonopoulos A; Wang S; Maemura T; Karamanska R; Lee C; Thompson AJ; Dell A; Kawaoka Y; Haslam SM; Paulson JC
    Nat Commun; 2023 Oct; 14(1):6178. PubMed ID: 37794004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an Enhanced High-Yield Influenza Vaccine Backbone in Embryonated Chicken Eggs.
    Guan L; Ping J; Lopes TJS; Fan S; Presler R; Neumann G; Kawaoka Y
    Vaccines (Basel); 2023 Aug; 11(8):. PubMed ID: 37631932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved Effectiveness.
    Rockman S; Laurie K; Ong C; Rajaram S; McGovern I; Tran V; Youhanna J
    Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensive heterogeneity in the hemagglutinin of egg-grown influenza viruses from different patients.
    Wang ML; Katz JM; Webster RG
    Virology; 1989 Jul; 171(1):275-9. PubMed ID: 2741346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule.
    Wood JM; Oxford JS; Dunleavy U; Newman RW; Major D; Robertson JS
    Virology; 1989 Jul; 171(1):214-21. PubMed ID: 2741341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus.
    Robertson JS; Bootman JS; Newman R; Oxford JS; Daniels RS; Webster RG; Schild GC
    Virology; 1987 Sep; 160(1):31-7. PubMed ID: 3629978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigetion into the attenuation of influenza viruses by serial passage.
    Beare AS; Bynoe ML; Tyrrell DA
    Br Med J; 1968 Nov; 4(5629):482-4. PubMed ID: 5697664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different tissue cultures for isolation and quantitation of influenza and parainfluenza viruses.
    Frank AL; Couch RB; Griffis CA; Baxter BD
    J Clin Microbiol; 1979 Jul; 10(1):32-6. PubMed ID: 227920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in Interferon-Stimulated Genes Contributes to High-Yield Production of Influenza Virus in Suspension MDCK Cells.
    Wang Q; Luo J; Li B; Ye Q; Xu W; Gao F; Zhou L; Lu W; Tan WS; Li X
    Vaccines (Basel); 2024 Mar; 12(3):. PubMed ID: 38543921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.